OrthoPediatrics Corp. (KIDS)
| Market Cap | 541.95M |
| Revenue (ttm) | 189.67M |
| Net Income (ttm) | -28.44M |
| Shares Out | 24.22M |
| EPS (ttm) | -1.24 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 170,470 |
| Open | 22.41 |
| Previous Close | 22.59 |
| Day's Range | 22.31 - 23.25 |
| 52-Week Range | 21.02 - 36.23 |
| Beta | 1.13 |
| Analysts | Buy |
| Price Target | 36.71 (+64.03%) |
| Earnings Date | Nov 6, 2024 |
About KIDS
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, ... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for KIDS stock is "Buy." The 12-month stock price forecast is $36.71, which is an increase of 64.03% from the latest price.
News
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
WARSAW, Ind., Dec. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
WARSAW, Ind., Nov. 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company dedicated exclusively to advancing the field of pediatric orthopedi...
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Trip Taylor - Gilmartin Group David Bailey - President & Chief Executive Officer ...
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
WARSAW, Ind., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
Additional details to be discussed during the Company's Investor Day today, September 12, 2024 Additional details to be discussed during the Company's Investor Day today, September 12, 2024
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
WARSAW, Ind., Aug. 20, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. (KIDS) Q2 2024 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS) Q2 2024 Earnings Conference Call August 6, 2024 8:00 AM ET Company Participants Trip Taylor - Gilmartin Group David Bailey - President & Chief Executive Officer Fr...
OrthoPediatrics Corp. Reports Second Quarter 2024 Financial Results and Reaffirms Full Year 2024 Revenue Guidance
WARSAW, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. Announces Private Financing
Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital
OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
WARSAW, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics,...
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
WARSAW, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced ...
OrthoPediatrics Corp. (KIDS) Q1 2024 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET Company Participants David Bailey - President, Chief Executive Officer Fred Hite - Chief Financial Officer,...
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
WARSAW, Ind., May 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics,...
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
WARSAW, Ind., April 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedic...
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children's Spine Symposium (ICSS)
WARSAW, Ind., April 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announce...
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp (KIDS) Q4 2023 Earnings Call Transcript
Call Start 08:00 January 1, 0000 9:04 AM ET OrthoPediatrics Corp (NASDAQ:KIDS) Q4 2023 Earnings Conference Call March 07, 2024 08:00 AM ET Company Participants Trip Taylor - Investor Relations David ...
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
Record full year 2023 revenue of $148.7 million increased 22% compared to prior year Record full year 2023 revenue of $148.7 million increased 22% compared to prior year
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
WARSAW, Ind., March 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics,...
OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
WARSAW, Ind., Feb. 28, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics,...
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
WARSAW, Ind., Feb. 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...
OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
WARSAW, Ind., Jan. 08, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics...